This case report describes the acute hemodynamic impact of transcatheter edge-to-edge repair in a patient with hypertrophic cardiomyopathy.
Treatment options for hypertrophic cardiomyopathy (HC) have evolved since Morrow’s first myotomy in 1961.1,2 The MitraClip device (Abbott) has been used as an adjunct to alcohol septal ablation (ASA) or as a single intervention in patients ineligible for septal reduction therapies.3 Herein, we describe a unique case of transcatheter edge-to-edge repair (TEER) in a patient who agreed to undergo TEER over ASA. Hemodynamic waveforms were recorded at rest and with dopamine infusion at 5 μg/min. Pressure was simultaneously recorded using a 4F pigtail catheter and an 8F sheath positioned in the left ventricle and aortic arch, respectively.
No takes yet. Share an insight, caveat, or question.
Turk et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: